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ABSTRACT The protein CA forms the mature capsid of human immunodeﬁciency virus. Hexamerization of the N-terminal
domain and dimerization of the C-terminal domain, CAC, occur during capsid assembly, and both domains constitute potential
targets for anti-HIV inhibitors. CAC homodimerization occurs mainly through its second helix, and is abolished when its sole
tryptophan is mutated to alanine. Previous thermodynamic data obtained with the dimeric and monomeric forms of CAC indicate
that the structure of the mutant resembles that of a monomeric intermediate found in the folding and association reactions of CAC.
Wehave solved the three-dimensional structure in aqueous solution of themonomericmutant. The structure is similar to that of the
subunits in the dimeric, nonmutated CAC, except the segment corresponding to the second helix, which is highly dynamic. At the
end of this region, the polypeptide chain is bent to bury several hydrophobic residues and, as a consequence, the last two helices
are rotated 90when compared to their position in dimeric CAC. The previously obtained thermodynamic data are consistent with
the determined structure of the monomeric mutant. This extraordinary ability of CAC to change its structure may contribute to the
differentmodes of association of CAduringHIV assembly, and should be taken into account in the design of new drugs against this
virus.
INTRODUCTION
During the last stages of infection byHIV-1, several thousand
copies of the Gag polyprotein self-associate on the membrane
of the infected cell and bud to form an immature capsid.
Subsequent to budding, Gag is proteolytically cleaved by the
viral protease into the mature proteins: the matrix, capsid
(CA), nucleocapsid, and p6, as well as the spacer peptides p2
and p1 (1–3). After the proteolytic cleavage, CA reassembles
to form the mature capsid (4). In vitro, CA spontaneously
assembles into cylindrical structures and cones resembling
the viral capsid (5–10). Several studies have shown that
capsid assembly is critical for viral infectivity (11–13). Thus,
inhibition of CA assembly by some mutations has a lethal
effect, and the alteration of capsid stability reduces virus
replication (11). Further, there is a wide body of evidence
suggesting that dimerization through its carboxy terminal
domain is a driving force in virus assembly (8,9,14,15).
CA of HIV-1 is formed by two independently folded
domains separated by a ﬂexible linker (16–19). The
N-terminal domain (residues 1–145 of the intact protein) is
composed of ﬁve coiled-coil a-helices, with two additional
short a-helices after an extended proline-rich loop (16–18).
The C-terminal domain (residues 146–231), CAC, is a dimer
both in solution and in the crystal form (19,20). Each CAC
monomer is composed of a short 310-helix followed by an
extended strand and four a-helices: a-helix 1 (residues 160–
172), a-helix 2 (residues 178–191), a-helix 3 (residues 195–
202), and a-helix 4 (residues 209–214), that are connected
by short loops or turnlike structures. The dimerization
interface is largely formed by the mutual docking of a-helix
2 from each monomer, being the side chains of each
tryptophan (Trp184) deeply buried in the dimer interface
(19,20). The two other aromatic residues in each monomer,
Tyr164 and Tyr169, are within the hydrophobic core of each
monomer, well away from the dimer interface. We have
previously described the folding and association reactions of
CAC, which involve a monomeric intermediate that re-
arranges and dimerizes to yield the native dimer (21). The
structure of this monomeric intermediate, as shown by CD
and ﬂuorescence, is nativelike with a solvent-exposed tryp-
tophan (21). This monomeric intermediate has been ob-
served in the thermal unfolding of the dimeric species by
FTIR and NMR spectroscopies (22). We have determined by
thermodynamic analysis, using alanine mutants, the ener-
getic contribution of each side chain at the dimerization
interface to the folding and association of CAC (23). These
studies have shown that the side chain of Trp184 (21,23) and
those of Ile150, Leu151, Arg154, Leu172, Glu175, Val181, Met185,
and Leu189 are key for CAC dimerization (23). Moreover, the
Trp184Ala mutant remains essentially monomeric at protein
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concentrations of hundreds of micromolar (23). The spec-
troscopic results, as well as the quantitative agreement of the
thermodynamic parameters (free energies and m-values) of
the folding of the nonmutated CAC and of the monomeric
CAC mutant Trp184Ala (23), indicate that the structure of the
latter may resemble that of the monomeric intermediate
detected during the folding and association of nonmutated,
dimeric CAC. To provide further insights into the association
of CA from HIV, we have solved the three-dimensional
structure of CAC mutant Trp184Ala in solution by NMR. In
this work, for the sake of clarity, the mutant will be referred
to as CACW40A to denote the position of the mutation in the
C-terminal domain; also, we will be numbering the amino
acids of CACW40A from its ﬁrst residue, i.e., the added
N-terminal methionine is Met1, and the second residue is Ser2
(which corresponds to Ser146 in the numbering of the intact
CA). The results revealed that, in CACW40A, only three of
the four native a-helices of CAC are stably formed. The
second helix seems to be involved in a conformational ex-
change equilibrium. The third and fourth a-helices (second
and third helices in CACW40A) are rotated 90 with respect
to its orientation in the nonmutated protein. The extraordi-
nary ability of the CAC monomer to change its structure may
contribute to the different modes of association of CA during
HIV assembly.
MATERIALS AND METHODS
Materials
Deuterium oxide was obtained from Apollo Scientiﬁc (Stockport, UK), and
the sodium trimethylsilyl [2,2,3,3-2H4] propionate, TSP, was from Sigma
(St. Louis, MO). Dialysis tubing with a molecular weight cutoff of 3500 Da
was from Spectrapor (Spectrum Laboratories, Ibaraki, Japan). Standard
suppliers were used for all other chemicals. Water was deionized and
puriﬁed on a Millipore system (Millipore, Billerica, MA).
Protein expression and puriﬁcation
The unlabeled mutant CACW40A protein was expressed in Escherichia coli
BL21(DE3) in Luria Broth and puriﬁed as described in the literature (21–
23), with the following modiﬁcations: 1), after ammonium sulfate precip-
itation, the protein was redissolved in 50 mM acetate buffer, pH 5.2; 2), the
same buffer containing NaCl was used to elute the protein from the SP- and
Heparin-Sepharose columns; and 3), before the size-exclusion chromato-
graphic step, the protein was dialyzed against 25 mM phosphate buffer, pH
7.3, and the solution supplemented with NaCl up to a ﬁnal concentration of
150 mM. Protein stocks were run in SDS-PAGE gels and found to be.97%
pure. The 15N-labeled sample was obtained by using Bioexpress medium
(Cambridge Isotope Laboratories, Andover, MA). The labeled protein was
puriﬁed with the same protocol. Protein concentration was calculated from
the absorbance measured at 280 nm, by using the extinction coefﬁcients of
amino acids (24). Samples were concentrated at the ﬁnal NMR concentration
by using Centriprep Amicon devices (Millipore), with a molecular weight
cutoff of 3500 Da.
Fourier transform infrared spectroscopy (FTIR)
Samples of nonmutated CAC and mutant CACW40A in phosphate buffer 10
mM, pH 6.8, were concentrated with Vivaspin devices (Vivascience,
Hannover, Germany), with a molecular weight cutoff of 5000 Da, to a ﬁnal
protein concentration of 160 mM. Volumes of 100 ml of this stock sample
were dried in a Speed Vac concentrator (Savant, Farmingdale, NY),
resuspended in D2O and incubated at room temperature for 90 min to
maximize the H-D exchange of the protein. Finally, the samples were dried
again, dissolved in 20 ml of D2O, and placed amid a pair of CaF2 windows
separated by a 50-mm thick spacer in a Harrick (Ossining, NY) demountable
cell. Spectra were acquired at 298 K on a model No. FTIR-66S instrument
(Bruker Optik, Ettlingen, Germany) equipped with a deuterated triglycine
sulfate detector and ﬁtted with a water bath (Thermo Haake, Paramus, NJ).
The cell container was continuously ﬁlled with dry air. Usually, 500 scans
per sample were taken, averaged, apodized with a Happ-Genzel function,
and Fourier-transformed to give a ﬁnal resolution of 2 cm1. The con-
tributions of the buffer spectra were subtracted, and the resulting spectra
were used for analysis, as described (25). The error in the estimation of the
percentage of secondary structure depends mainly on the removal of spectral
noise, and based on several model proteins, this error was estimated to be 2%
(25). To be conservative, we have considered that in our band decomposition
the estimated error was 4%.
Protein secondary structure components were quantiﬁed from curve-
ﬁtting analysis by band decomposition of the original amide I9 band after
spectrum smoothing. Spectrum smoothing was carried out by applying the
maximum entropy method, assuming that noise and band shape follow a
normal distribution. The minimum bandwidth was set to 12 cm1. The
resulting spectra had a signal/noise ratio .4500:1. Derivation of IR spectra
was performed using a power of 3, breakpoint of 0.3, and Fourier self-
deconvolution was performed using a Lorentzian bandwidth of 18 cm1 and
a resolution enhancement factor (the so-called factor k) of 2.0. To quantify
the secondary structure, the number and position of the absorbance band
components were taken from the deconvoluted spectra; the bandwidth was
estimated from the derived spectra; and the absorbance height from the
original spectra. The iterative curve-ﬁtting process was performed under
Spectra-Calc (Galactic Industries, Salem, NH). The number, position, and
band shape were kept ﬁxed during the ﬁrst 200 iterations. The ﬁttings were
further reﬁned by allowing the band positions to vary for 50 additional
iterations. The agreement between experimental and theoretical spectra was
assessed from the x2 values (within the range 13 105 to 4.53 105). The
area of the ﬁtted absorbance band components was used to calculate the
percentage of secondary structure.
NMR samples
All NMR experiments were acquired on a model DRX-500 spectrometer
(Bruker) equipped with a triple resonance probe and z-pulse ﬁeld gradients.
Homonuclear 1D- and 2D-NMR experiments were performed with ;1 mM
samples in 0.5 ml at 293, 298, and 303 K, pH 7 (uncorrected for deuterium
isotope effects) in either H2O/D2O (90%/10%, v/v) or D2O. Heteronuclear
two- and three-dimensional spectra were acquired at 293 K. Centriprep
Amicon devices (Millipore) were used to exchange the sample in 100%
D2O, during 4 h at 278 K. TSP was used as the internal chemical shift
reference in the homonuclear experiments.15N chemical shifts were refer-
enced following the method of Wishart (26).
Translational diffusion measurements
(DOSY experiments)
Translational self-diffusion measurements were performed with the pulsed-
gradient spin-echoNMRmethod (27,28). The following relationship exists be-
tween the translational self-diffusion coefﬁcient, D, and the NMR parameters,
I
I0
¼ exp Dg2Hd2G2 D
d
3
 t
2
  
; (1)
where I is the measured peak intensity of a particular (or a group of)
resonance(s); I0 is the maximum peak intensity of the same resonance(s) at
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the smaller gradient strength;D is the translational self-diffusion constant (in
cm2 s1); d is the duration (in seconds) of the gradient; G is the strength of
the gradient (in T cm1); D is the time (in seconds) between the gradients;
and t is the recovery delay between the bipolar gradients (100 ms). Data are
usually represented as the ln(I/I0) vs. G2, and the slope of the line is
Dg2Hd
2ðD d=3 t=2Þ; from where D can be easily obtained.
The Stokes-Einstein equation relates D with the R, the hydrodynamic
radius of the sphere, and the viscosity of the solvent, h, according to
R ¼ kT
6phD
; (2)
where T is the temperature (in K) and k the Boltzmann constant.
The viscosity of a solution is very weakly inﬂuenced by the macromol-
ecule component at the concentrations used in the NMR studies, and
therefore, the viscosity of the solution is that of the solvent. Solvent viscosity
is temperature-dependent, according to Lapham et al. (29): logh ¼
a1½b=ðc TÞ: The terms a, b, and c are given for a particular D2O:H2O
ratio. In our conditions, a 100% D2O solution, the values are a ¼ 4.2911,
b ¼ 164.97, and c ¼ 174.24. This yields a value of h ¼ 1.253 kg/(cm s) at
293 K, used in our calculations.
The gradient strength was calibrated by using the diffusion rate for the
residual proton water line in a sample containing 100% D2O in a 5-mm tube,
and backcalculating G. Experiments were acquired with a postgradient
eddy-current relaxation delay of 5 ms. Each experiment was averaged over
128 scans and the number of points was 16 K. The strength of the gradient
was varied from 2% of the total power of the gradient coil to 95%, with a
sine function shape. The largest protein concentration used was 1 mM, and
the other used concentrations were dilutions of that protein stock. The
duration of the gradient was varied between 2.2 and 3 ms, and the time
between both gradients was between 100 and 150 ms. The most upﬁeld-
shifted methyl groups were used to measure the changes in intensity.
1D-, 2D-, and 3D-NMR spectroscopy
All spectra were acquired in the phase-sensitive mode. Frequency discrim-
ination in the indirect dimensions was achieved by using either the time-
proportional phase incrementation technique, TPPI (30), or States-TPPI (31).
One-dimensional spectra were acquired with 16 K data points, averaged
over 512 scans with 6000 Hz of spectral width (12 ppm). 1H homonuclear
TOCSY (32), using theMLEV-17 sequence, withmixing times of 45, 60, and
80 ms (33), and NOESY (34) spectra with 80, 150, and 200 ms mixing times
were recorded by standard methods with water suppression achieved by
WATERGATE (35).Usually, the size of the acquisition datamatrixwas 2048
3 512 points in t2 and t1, respectively, with 64 scans (TOCSY) or 128 scans
(NOESY) per increment in the t2 dimension. The spectral width was 6000 Hz
in both dimensions. Before Fourier transformation, the two-dimensional data
matrix was multiplied by a phase-shifted sine bell or square sine bell function
in both dimensions. The corresponding shift was optimized in every
experiment. Base-line correction and zero-ﬁlling were applied in both
dimensions. All spectra were processed and analyzed by using XWINNMR
(Bruker AXS, Karlsruhe, Germany) working on a PC computer.
Heteronuclear experiments included 15N-HSQC (36), three-dimensional
15N- TOCSY-HSQC (37), three-dimensional 15N-NOESY-HSQC (37), and
HNHA (38). Spectral widths were 6000 Hz for 1H and 1000 Hz for 15N.
Mixing times for the NOESY experiments were 150 and 200 ms, and 45, 60,
and 80 ms for the TOCSY experiments. In the three-dimensional experi-
ments, 2 K data points were acquired in the t3 dimension (
1H), and 64 and
512 scans were acquired in the t2 and t1 dimensions, respectively. In the 2D-
HSQC experiments, 4 K data points were obtained in the 1H dimension and
128 scans were acquired in the 15N axis.
Geometrical restraints
1H NMR resonances were assigned by using standard sequential assignment
procedures (39). Spin systems were identiﬁed by analysis of the two- and
three-dimensional TOCSY experiments. The use of the three temperatures
and the two- and three-dimensional experiments allowed us to resolve most
of the ambiguities that arose from chemical shift degeneracies. All spectra
were analyzed by using the Sparky software (40).
The signals from the 2D-NOESY experiment recorded at 150 ms were
used as input for the structure calculation. After integration, the peak volumes
and chemical shifts list were output to a CYANA-compatible format (41).
The automatic calibration method implemented in CYANA, CALIBA (42),
was run to transform the peak volumes into distances. Default weighting fac-
tors were attributed to the different restraint categories for different types of
atoms. The upper limits obtained were used without modiﬁcation for the ini-
tial structure calculations.
The assignment of cross-peaks in the NOESY spectrum was carried out
in several steps. A preliminary NOE data set (;500 NOEs) was used to
calculate initial structures with CYANA. The resulting conformers with the
lowest target functions were used to assign additional peaks in the NOESY
spectrum. The cycle of calculations and assignments was repeated until no
further assignments were possible. The quality of the introduced constraints
was checked at every step by analyzing the restraint violations of the
calculated conformers. The NOE cross-peaks corresponding to restraints that
were consistently violated in a signiﬁcant number of structures were checked
for possible overlap in the 3D-NOESY, and the corresponding restraints
were modiﬁed. The cycle was repeated until no consistent violation was
detected. An example of this procedure is exempliﬁed by the region Ser34 to
Ala40, where no cross-peaks in the HSQC spectrum were observed (see
Results). However, the ﬁrst runs of the structure calculations indicated the
proximity between the aliphatic chains of residues in this region and the
aromatic moieties at the ﬁrst helix (Phe17, Tyr20, Tyr24, and Phe25). If such
proximity was observed in greater than three-quarters of the calculated struc-
tures, and there were unassigned NOEs involving the aromatic moieties, then
those NOEs were tentatively assigned, involving the side chain of a residue
in that region.
Slowly exchanging amide protons were identiﬁed in a 2D-NOESY
recorded after the exchanging step. Hydrogen-bond restraints were included
in the last steps of the calculation if 1), the amide proton signal was observed
in the exchange NOESY experiment; and 2), the hydrogen bond was present
in at least one-third of the structures inspected. Each hydrogen bond was
speciﬁed by two distance restraints: HN-O distance of 1.7–2.3 A˚ and N-O
distance of 2.4–3.3 A˚.
The 3JHNHa coupling constants were measured from a 3D-HNHA, and
the corresponding backbone dihedral f-angles obtained by means of the
appropriate Karplus curve (38). The 3JHNHas measured were not corrected
for relaxation effects and were likely to be 5–10% underestimated (43).
Backbone f-angles were constrained to –60 6 30 for 3JHNHa , 5.5 Hz,
and –120 6 60 for 3JHNHa . 7 Hz. From the ratio between intraresidue
and sequential HN-Ha NOESY cross-peak intensities and the secondary
structure indicated by the conformational shifts of the Ha protons, the
c-torsion angles were extracted, and introduced as constraints. The confor-
mational shifts of the Ha protons were obtained from the tabulated random-
coil values (39).
In the last rounds of the calculations, stereospeciﬁc assignments of
diastereotopic protons were included. Stereospeciﬁc assignments were carried
out by using the GLOMSA module of CYANA (42). The stereospeciﬁcally
assigned protons were: Asp8 (Hb), Arg
10 (Hg), Pro
13 (Hd), Pro
16 (Hb), Phe
17
(Hb), Arg
18 (Hb), Arg
29 (Hb), Leu
46 (Hb), Val
47 (Hg), Gln
48 (Hb,Hg), Pro
52
(Hb), Leu
61(Hb), Leu
67 (Hb, Hd), Glu
68 (Hb), and Glu
69 (Hb).
Structure calculations and analysis
All histidine, arginine, and lysine residues were regarded as positively
charged, and glutamate and aspartate side chains as negatively charged. In
the NOESY experiments, all proline residues (namely, Pro13, Pro16, Pro52,
and Pro63), except Pro3 and Pro80, which could not be assigned, were in a
trans conformation, as concluded from the HaHd NOEs with the
corresponding preceding residues. A total of 500 random conformers were
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annealed in 12,000 steps. The 50 conformers with the lowest target function
constituted the ﬁnal family. Each member of this family was subjected to
restrained energy minimization by using the AMBER 8 package (44). Force-
ﬁeld constants of 32 kcal mol1 A˚2 and 32 kcal mol1 rad2 were used for
NOE and torsion angle constraints, respectively. Thus, calculations were
carried out with the standard force ﬁeld of the program in vacuo plus the
NOEs and angle constraint terms.
The quality of the structures was evaluated in terms of deviations from
ideal bond lengths, angles, and through Ramachandran plots by using
PROCHECK (45) and PROCHECK-NMR (46). Based on those analysis,
the coordinates of the 30 best structures of the AMBER family were chosen.
Structures have been represented either with PyMOL (47) or MOLMOL (48).
RESULTS
FTIR measurements
We determined the percentage of secondary structure of
CAC and CACW40A by FTIR, since this technique uses
similar concentrations to those employed in NMR experi-
ments. Previously, we have reported that at CD concentra-
tions (in the range of mM), the percentage of helicity was
identical in CACW40A and in the nonmutated protein
(21,23). The results obtained by using FTIR show that CAC
and CACW40A had the same degree of helicity (Table 1),
and conﬁrm our previous CD results, indicating that the
structure of the mutant is similar at the concentrations used in
NMR and CD.
It is important to indicate here the caveats of the FTIR
technique when comparing the a-helical content of both
proteins. In both proteins, there was a clear band assigned
unambiguously toa-helix, at 1650 cm1 (Table 1), whichwas
shifted at smaller wave-numbers in the nonmutated CAC.
Further, in both proteins there was a band at 1660 cm1,
which could be assigned to either 310 or a-helix (both kind of
structures were present in both protein species); and ﬁnally,
both proteins had a band at 1626 cm1,whose assignmentwas
ambiguous (51–53). Taken together, it is not possible, given
the uncertainties, to make a statistical analysis of the exact
content of the a-helical structure in both proteins. We can
provide, however, an estimation of the overall content of
helical structure in both proteins, and conclude that, within the
limitations of FTIR and the experimental uncertainty, the
helical content in both proteins was identical. This result
agrees with that obtained by CD (21), since at the same
concentration of monomeric species, no differences in the
measured ellipticities are observed in the far-UV CD spectra
of both proteins.
CACW40A is monomeric at NMR concentrations
Some CAC mutants, which, at moderate concentrations,
revealed no detectable tendency to dimerize, could show a
monomer-dimer equilibrium at the high concentrations used
forNMRstudies. To determinewhether CACW40Awasmono-
meric under NMR conditions, we carried out DOSY experi-
ments in the concentration range from 50 mM to 1 mM.
The translational diffusion coefﬁcient of CACW40A in-
creased linearly as the protein concentration decreased (Fig.
1 B), since at lower protein concentrations, the molecular
impairment of the translational diffusion was smaller. The
extrapolated D at inﬁnite dilution of the protein (i.e., the
y-axis intersection) was 1.206 0.043 106 cm2 s1 at 293 K.
Equation 2 yielded a hydrodynamic radius for a spherical
CACW40A of 14.2 6 0.3 A˚.
The hydrodynamic radius for an ideal unsolvated spherical
molecule can be theoretically calculated considering that the
anhydrous molecular volume,MV=N; equals the volume of a
sphere (54,55),R, and thusR ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
3MV=4Np;3
p
whereM is the
molecular mass of the protein, V is its partial speciﬁc volume,
and N is the Avogadro’s number. The molecular mass of a
monomeric CACW40A is 9534.9 Da, and V ¼ 0:717 cm3=g
as calculated from amino-acid composition (55). The above
expression led to a hydrodynamic radius of 13.9 A˚, which
agrees very well with that obtained from diffusion measure-
ments. We then conclude that CACW40A is monomeric in
solution even at millimolar concentrations, and we can
anticipate that its shape is nearly spherical.
In addition to the results of the DOSY experiments
supporting the monomeric state of CACW40A at millimolar
concentrations, there are other independent pieces of evidence
supporting the above conclusion. First, previous ultracentri-
fugation experiments have shown that CACW40A was
monomeric up to concentrations of 23 mM, and probably, to
much higher concentrations (19); the lowest concentration
used in theDOSY experimentswas 50mM(Fig. 1B). Second,
gel ﬁltration chromatography has shown that CACW40A
remains monomeric at protein concentrations of hundreds of
micromolar (23). Third, NMR relaxation measurements were
carried out at two different concentrations (1mMand 400mM,
TABLE 1 Secondary structure analysis of nonmutated CAC
and CACW40A as determined by FTIR
Percentage of secondary structure
Wavenumber
(cm1)*
Nonmutated
CAC CACW40A
Structural
assignmenty
1673.7 9.4 8.2 Turns
1660.3 15.2 6.9 310-helix/a-helix
1650.1 48.7 a-helix
1647.1 41.3 a-helix
1635.5 17.0 23.6 —z
1625.7 9.8 6.3 Extended chains
*Errors in the wavenumbers are estimated to be 62 cm1.
yThere is one more band centered at 1614 cm1. This band is assigned to the
amino-acid side chains (49) and it accounts for 6% of the total area of the
amide I9 band. The percentages of secondary structure shown in the table
do not take into account the contribution of this band. The 1673.7 cm1
component corresponds to turns (49); the 1660.3 cm1 band is assigned to
310- and a-helix structures (50,51); the 1650.1 and 1647.1 cm
1 bands are
assigned toa-helix (49,52); and the 1625.7 cm1 band is assigned to extended
chains (50).
zThe assignment of the 1635.5 cm1 band remains ambiguous (51–53), since
it has been reported that it can arise from extended segments that do not form
sheets, distorted helical, and/or b-structures.
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which overlap with the concentration used in the DOSY
experiments; see Fig. 1), and they did not show any variation
in the rates as the protein concentration was varied (data not
shown). Fourth, and ﬁnally, DOSY measurements, in other
proteins, have been shown to constitute an unambiguous
probe to determine protein aggregation and oligomerization
even at protein concentrations,100mM (56–62), and whose
results have also been supported by other biophysical
techniques (63,64).
Assignment of CACW40A
In the 2D-HSQC, 63 cross-peaks (out of the expected 80
signals) could be clearly identiﬁed. The intensity and the
broadness among the cross-peaks in the HSQC was very
different, suggesting that some amino acids were affected by
movements within several timescales. For instance, the
cross-peaks of residues Ser34 to Ala40, except those of Val37
and Lys38, were not present at any of the explored tem-
peratures. These residues are close to the mutation site,
Ala40, and the absence of resonances could be due to line
broadening, arising from conformational exchange. Absence
of signals in HSQC experiments due to exchange processes
has also been observed in loops and highly mobile regions
(65,66). Resonances of residues at the N-terminus, Ser2 to
Ser5, and at the C-terminus, Pro80 to Leu87, could not be
unambiguously assigned (Supplementary Material, Table
S1). Sequential cross-correlations were established based on
Ha-HN (or Ha-Hd for proline residues), Hb-HN, and/or HN-
HN NOEs observed between adjacent residues. For all the
residues unambiguously assigned, at least one sequential
NOE could be identiﬁed.
The intensities of the main chain NOEs, the observed
short-, medium-, and long-range NOEs, and the conforma-
tional chemical shifts of the Ha resonances indicated that the
secondary structure of CACW40A in solution consists of
three a-helices (Fig. 2). A total of 24 amide protons showed
protection. The location of these protected amide protons is
in agreement with the limits of secondary structure deter-
mined by NOE data (Fig. 2).
The cysteine residues, Cys54 and Cys74, were spatially
close, as shown by the Hb-Hb NOEs between both residues
and the NOEs between the side chains of Cys54 and Met71.
However, no disulﬁde-bond restrictions were included dur-
ing the calculations (which could have helped in lowering
the target function and the ﬁnal RMSD). The presence of a
disulﬁde bridge has been observed in the nonmutated dimer
(20,21,67), but the percentage of free thiols in freshly
puriﬁed protein was found to be as large as 50% (20). In a
recent crystallographic study, where the nonmutated CAC
was bound to a peptide, the disulﬁde bridge was present in
the nonbound protein, but it was absent in the unliganded
protein (67). However, in CACW40A, due to the absence of
a larger number of NOES between both cysteine residues or
between adjacent residues, we preferred not to include the
disulﬁde bond as a restriction. This precaution has provided
to be certain since in some of the structures of the family
ensemble of CACW40A, the side chains of both cysteine
residues are not close enough to form the covalent bond.
Calculation of the solution structure of CACW40A
A total of 927 NOEs were collected and translated into 779
relevant distance restraints; further, 66 angle restraints and
40 hydrogen-bond restraints (two for each hydrogen bond)
were included in the calculations. The 50 structures with the
lowest target functions from CYANA had an average target
function of 0.88 (with a minimum at 0.39 and a maximum at
1.18), and an RMS deviation of 1.206 0.20 A˚ for backbone
residues and 1.73 6 0.22 for all atoms in the ordered poly-
peptide region (Leu7-Gln75). The NMR structure of CACW40A
is represented by the best 30 conformers obtained by AMBER
(Table 2). The elements of secondary structure comprising
the three a-helices are among the best deﬁned regions of the
protein (Fig. 3).
FIGURE 1 DOSY-NMR experiments of CACW40A. (A) The logarithm
of the normalized intensity of the most upﬁeld-shifted peaks is shown as a
function of the squares of the gradient strengths at two concentrations: 1 mM
(continuous line and open squares) and 500 mM (dotted line and solid
squares). The slopes of the plots give the apparent diffusion constant of the
molecule in solution at the particular concentration used. (B) NMR diffusion
coefﬁcients of the protein as a function of protein concentration. The bars are
ﬁtting errors to Eq. 1. The solid line is the ﬁtting to a linear equation whose
y-axis intersection yields the diffusion coefﬁcient at 0 M protein concentration.
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Description of the structure
The overall shape of the molecule is nearly spherical (Fig.
4), conﬁrming the results from DOSY measurements. The
N-terminal region (residues 1–7) was largely disordered and
solvent-exposed (Fig. 3 A). However, there are long-range
NOEs between the side chains of Ile6 and Phe24, indicating
that the former residue is close to the core of the protein. In
25 conformers out of 30, hydrogen bonds are observed
between the NH of Ile9 and the CO of Ile6; and in 15
conformers, the hydrogen bond between Asp8 to Ser5 is
present (both hydrogen bonds were not included during the
calculations). Further, short-range NOEs are observed
between Ile9 and Leu7, and Ile9 and Ile6, and sequential
NH-NH protons are present for the patch Leu7 to Ile9 (Fig.
2). Taken together, these data indicate the presence of a 310-
helix turn, comprising residues Leu7-Ile9.
This 310-helix is followed by a type I b-turn formed by
Arg10 to Lys14, as suggested by the hydrogen bond between
Lys14 and Gly12 (which was not included during the
calculations) and angle analysis. This region is immediately
followed by the ﬁrst a-helix, comprising residues Phe17 to
Arg29. Fraying at the N- and C-termini of the helix is
observed, as concluded from the hydrogen bonds between
Tyr20 and Phe17 (which was not included in the calculations),
Ala30 and Thr27, and Gln31 and Leu28.
The ﬁrst a-helix contains the four aromatic residues of the
protein, namely Phe17, Tyr20, Phe24, and Tyr25, which form
the main core. The side chain of Val21 is deeply inserted in
the core as shown by NOEs with the side chains of Leu46,
FIGURE 2 Summary of NMR data. NOEs are classiﬁed into strong, medium, or weak, according to the height of the of bar. The corresponding sequential
Ha NOEs with the following Hd of the proline residue are indicated by an open bar in the row corresponding to the aN (i, i11) NOEs. The light bars indicate
residues detected in a two-dimensional NOESY experiment after 4 h of exchange. Residues whose conformational shifts were .0.1, positive or negative, are
represented by a 1 or , respectively; 0 indicates those residues whose conformational shifts are (positive or negative) ,0.1; and the * indicates the glycine
residues, with two different chemical shifts for each Ha proton. The 3JNHHa are represented by a dark bar for those residues with a value,5.5 Hz, as measured
from HNHA experiments.
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Val47, and Met71. Thus, all these NOEs anchor the C-terminal
region of the protein to the ﬁrst helix.
After the ﬁrst helix a long loop bulges out, whose residues
show a large RMS deviation, especially at the N-terminus
(Fig. 3 B). Conversely, residues Thr44, Leu45, Leu46, and
Val47 are forming the core of the protein with a low RMS
deviation (Fig. 3 B). All these residues belong to the second
a-helix in the nonmutated CAC. Thereafter, the second helix
(residues Asp53 to Lys59) is highly regular, showing NOEs
with Phe17 and with the third a-helix (residues Glu68 to
Met71). The following residues, Gly62 to Ala65, adopt a type
II b-turn. The last helix is formed by residues Thr66 to Cys74
and it is well deﬁned; in this helix, residues Met70, Met71, and
Thr72 are buried. The second and third helices are arranged in
a parallel way between them, and in a perpendicular fashion
to the ﬁrst helix (Fig. 4, B and C).
The analysis of the variances of the 30 conformers with
PROCHECK-NMR (46) for the f-, c-, and x1-angles showed
that the polypeptide patches Phe17 to Leu28, Asp53 to Leu58,
and Glu68 to Ala73 have the smaller variance, with backbone
angles close to those expected for ideal a-helices (f- and
c-angles), or with side chains in a well-ﬁxed conformation
(for the x1-angle).
DISCUSSION
Structural comparison between the dimeric and
monomeric forms of CAC
The structure of the monomeric CACW40A consists of a
one-turn of a 310-helix at its N-terminus and three a-helices
connected by loops (Fig. 4). The structural features, and the
similarities and differences with each subunit in dimeric
CAC are discussed next.
The one-turn 310-helix (Leu
7-Ile9) of dimeric CAC is also
formed inmonomeric CACW40A (Fig. 4), as concluded from
the FTIRmeasurements (Table 1), and the observed medium-
range NOEs (Fig. 2). The hydrogen-bonding scaffold of the
helix was not very stable, as concluded from 1), the hydrogen
FIGURE 3 Solvent-accessible surface area (A) and root
mean-square deviations from mean coordinates (B) per
residue. Calculation of the solvent-accessible surface area
was carried out with MOLMOL (using a solvent radius of
1.4 A˚) (48). The main-chain and side-chain RMS devia-
tions (in A˚) are indicated in black and red, respectively.
The bars at the top of the panels indicate the a-helices.
TABLE 2 NMR restraints and structural statistics for the best
30 structures
Restraints and statistics
Total number of restraints 885
NOE restraints 779
Intraresidue (i-j ¼ 0) 249
Sequential (ji-jj ¼ 1) 183
Medium range (ji-jj # 4) 200
Long range (ji-jj $ 4) 147
Dihedral angle restraints 66 (for the f-
and c-angles)
Hydrogen-bond restraints 20 3 2
Average number of NOE violations . 0.3 A˚ 0.23
RMSD from average structure
(residues Leu7 to Gln75)
Backbone (A˚) 1.2 6 0.1
Heavy atoms (A˚) 1.8 6 0.4
Ramachandran statistics
Most favored region (%) 60.0
Additionally allowed (%) 35.3
Generously allowed (%) 4.3
Disallowed (%) 0.4
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exchange experiments (Fig. 2); and 2), the fact that some
hydrogen bonds are not present in all the structures. Thus, the
310-helix in CACW40A shows a nativelike conformation
with a high ﬂexibility.
The ﬁrst a-helix of dimeric CAC (Phe17 to Arg29) is also
present in CACW40A, although the behavior of the four
aromatic residues was different to that observed in non-
mutated CAC. Whereas Tyr20 and Phe24 showed native
contacts (with Leu46 and Asn49; and, with Leu45 and Leu46,
respectively), Phe17 and Tyr25 adopted nonnative orienta-
tions:
1. In dimeric CAC, the side chain of Phe17 extends into the
hydrophobic cluster formed by the last two helices, being
close to the side chains of Cys54, Leu58, Met70, Met71,
and Cys74 (19,20,67). In monomeric CACW40A, NOEs
between the side chains of Phe17 and Leu58, Met70,
Met71, and Cys74 were detected. However, nonnative
NOEs were also observed between Phe17 and the side
chains of Leu46 and Val47. Residues Leu46 and Val47 are
separated from the side chain of Phe17 .6 A˚ in the
nonmutated CAC (19,20). Thus, Phe17 in CACW40A
adopts a dual role: ﬁrstly, it anchors the last region of the
protein to the ﬁrst helix in a nativelike environment; and
secondly, it forces the long disordered loop to stay closer
to the ﬁrst helix, adopting a nonnative conformation.
2. In dimeric CAC, Tyr25 is close to Val21, Thr27, Leu28,
Arg29, Thr42, and Leu67 (19,20,67). In monomeric CAC-
W40A, the side chain of Tyr25 showed NOEs with the side
chains of Val21, Leu28, Leu67, but also with that of Leu46.
Then, both aromatic residues adopt a nonnative confor-
mation, as shown by the nonnative NOEs with the side chains
of Leu46 and Val47 (these residues also have nonnative
contacts with Val21). It is tempting to suggest that the changes
in the orientation of the aromatic moieties in the ﬁrst helix are
modulated by the proximity of Thr42, Thr44, Leu45, Leu46,
and Val47. In dimeric CAC, these latter residues form the last
turn of the second helix, where a kink occurs (19,20). Since
this helix is not stably formed in CACW40A (see below), the
protein must hide most of its hydrophobic residues from the
solvent; the solution adopted is to bend the C-cap region of
the second helix making nonnative contacts with the middle
and last regions of the ﬁrst a-helix (Fig. 4 C).
The last two helices are parallel to each other (Fig. 4, A
and B), as in dimeric CAC (19,20,67). However, as the
region between Leu45 and Asn49 is bent, the last two helices
are arranged perpendicularly to the orientation adopted by
the same helices in nonmutated dimeric CAC (Fig. 4 B), and
are, thus, in a nonnative conformation.
We also inspected whether the highly conserved region in
CA from retroviruses, known as theMHR, adopts a nativelike
conformation in CACW40A. In dimeric CAC, the conserved
MHR residues (Asp8 to Leu28) form a compact strand-turn-
helix motif, stabilized by an extensive hydrogen-bonding
network (19,20,67). This network involves the side chains of
Arg10, Gln11, Glu15, Arg23, and Asn51. We could not detect
any of these hydrogen-bonds in the calculated structures.
However, twopieces of evidence suggest that theMHRadopts
a nativelike conformation in CACW40A. Firstly, the structure
and orientation of ﬁrsta-helix is nativelike (Fig. 4A and Fig. 5
A). And secondly, theHd protons of Arg
10 andArg23 did show
different chemical shifts, suggesting a ﬁxed conformation for
both side chains (Supplementary Material, Table S1).
The CACW40A does not form dimeric species due to the
absence of the indole moiety, with the loss of van der Waals
and hydrophobic interactions. However, due to the absence
of the tryptophan side chain, the conformations of other
residues involved in the dimerization surface of nonmutated
CAC were changed. Residues, which showed dimer con-
tacts, were (19,20,67): Thr2, Ser5, Ile6, Leu7, Asp8, Arg10,
Glu31, Glu32, Ala33, Ser34, Glu36, Val37, Trp40 (which is an
alanine residue in the monomeric CACW40A), Met41,
Glu43, Thr44, Leu45, Val47, Gln48, Asn49, Lys59, and Pro63.
In monomeric CACW40A, Thr2, Ser5, Glu31, Glu32, Ala33,
Ser34, Glu36, and Ala40 were not completely assigned or not
assigned at all (Supplementary Material, Table S1), probably
due to line broadening, as it has been discussed. It seems,
that in the absence of quaternary interactions, those residues
are exploring different conformations (see below). Residue
Val37 showed different f- and c-angles to those observed for
the residue in nonmutated CAC. The region from Met41 to
Asn49, which makes contact in the nonmutated CAC with the
MHR region of the other monomer (19,20,67), adopted a
nonnative conformation in monomeric CAC, which allowed
the burial of a hydrophobic surface (see above). Residues
Ile6 to Arg10, which in the dimeric protein are closer to the
dimerization helix (residues Thr44 to Asn49), showed a sim-
ilar structure in both species (see above), but no long-range
FIGURE 4 Structure of CACW40A. Different views of the ensemble of
the best 30 structures of CACW40A. The perpendicular arrangement of the
last two helices with the ﬁrst one is best shown in panel A; the parallel
arrangement between the last two helices is best shown in panel B; and, the
proximity between the long disordered loop and the ﬁrst helix is best shown
in panel C. The ﬁgures were produced with MOLMOL (48). The N and C
letters indicate the N- and C-termini of the protein, respectively.
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NOEs were observed with the region Thr44 to Asn49. Then, it
seems that the secondary structure of the polypeptide patch
Ile6 to Arg10 is not regulated by quaternary interactions with
the other monomer. Finally, Lys59 and Pro63 in CACW40A
showed similar backbone angles to those observed in the
nonmutated protein, but they did not show contacts with the
N-terminus of the protein, due to the rotation of this region.
The structure of CACW40A and its implications
for understanding folding and association of
CA of HIV-1
The folding and association of nonmutated CAC (either by
chemical- or heat-denaturation) involves a monomeric
intermediate (21–23). The spectroscopic evidence from CD
and the very similar values for the thermodynamic param-
eters in chemical denaturation experiments (free energy and
m-values) for the monomeric intermediate of nonmutated
CAC and the monomeric CACW40A mutant (21) indicate
that both monomeric forms are very similar. This monomeric
intermediate does not expose to the solvent a large amount of
hydrophobic patches as concluded from the lack of 8-anilino-
1-naphtalene-sulfonate binding at room temperature (21,22).
However, during the thermal unfolding of nonmutated CAC,
the monomeric species binds 8-anilino-1-naphtalene-sulfonate
(22). With the structure of CACW40A in hand, we suggest
that upon heating, the loop region, which makes nonnative
contacts, separates from the ﬁrst a-helix, exposing the hydro-
phobic residues.
The NMR structure of CACW40A is highly consistent
with spectroscopic observations of this mutant carried out by
CD and FTIR. However, there is an apparent contradiction.
In the structure of the nonmutated CAC, helix 2 (the
dimerization helix) is fully formed (19,20) but not in the
monomeric CACW40A (Fig. 4). If helix 2 was totally
unstructured in the monomeric form, one could, in principle,
expect a signiﬁcant decrease in helicity relative to the dimer,
determined by CD and FTIR; this decrease is not observed
either in the monomeric intermediate of CAC or in the
CACW40A mutant ((21) and Table 1). It could be argued
that 1), in CACW40A the putative decrease in absolute
ellipticity at 222 nm might be counterbalanced by a similar
increase due to the different environment adopted by the
aromatic residues (see above), which also absorb at 222 nm
(68,69); and 2), that the mathematical deconvolution of the
FTIR spectrum might be unreliable. We cannot rule out the
errors in the deconvolution procedure of FTIR, but the method
is robust enough, as it has been shown in determination of
secondary structure of model proteins (49–51). Either way,
we cannot rule out that there is a compensation in the ellip-
ticities upon aromatic rearrangements, although we believe
that an exact matching is highly improbable. We favor a
simpler explanation based in the reported fact that highly
ﬂexible proteins can yield almost nativelike spectra by CD
(as well as by other probes), if the interconversion between
the different conformations is fast enough (70). We have
shown that the segment formed by residues Ser34 to Glu36
and residues Asn39 to Ala40 could not be assigned. The rea-
son behind the absence of assignments is the lack of ob-
servable resonances, not the inability to assign the observed
ones. The only reasonable explanation for the missing peaks
is that those residues are involved in a conformational
exchange process that broadens the signals beyond detection
(65,66). Such exchange process could be due to exchange of
amide protons with the solvent, or to interconversion be-
tween different conformers (conformational exchange). The
NMR experiments described in this work were acquired with
gradients, which minimize the amide protein exchange with
solvent; further, control NOESY experiments were acquired
at 283 K, to reduce solvent exchange, and still no resonances
could be observed for residues in that region (data not shown).
Thus, we propose that this region of monomeric CAC sam-
ples a nativelike conformation (as shown by CD and FTIR)
and one or more partially folded states. These equilibria should
be intermediate in the NMR timescale, but fast enough in the
FTIR and CD time regimes.
Unfolding of helical elements has been observed in other
helical proteins when a cofactor has been removed (66), or
when a single residue has been mutated (71,72). Interestingly
enough, a helical region in wild-type apocytochrome b562
(residues 1–20) is unstructured in a single point mutant (71).
This mutant shows also nonnative contacts that involve the
aromatic moieties of the core, similar to what is observed in
CACW40A. The structure of the apocytochrome b562 mutant
has been proposed to be similar to that of an unfolding
intermediate, detected by kinetic methods. However, there is
FIGURE 5 Comparison of the structures of each subunit in nonmutated,
dimeric CAC and in monomeric CACW40A. (A) Ribbon diagrams of the
superposition of a subunit in dimeric CAC (Protein Data Bank: 1A43) (light
blue) with the best structure of CACW40A (green). (B) The same
superposition of the structures in panel A, as viewed from the bottom of
the orientation shown in panel A. The ﬁgures were produced with PyMOL
(47), and the CAC structure was protonated with MOLMOL (48).
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an important difference between the partially unfolded state
of CAC and that in apocytochrome b562. In the apocyto-
chrome b562 mutant, the rest of the protein scaffold remains
nativelike, while in CACW40A, the last two helices are
rotated when compared to nonmutated CAC. To the best of
our knowledge, this is the ﬁrst example where such major
rearrangements have been described, as a consequence of a
single mutation. It could be thought that this rotation was the
result of the structure calculation. However, several lines of
evidence argue against the possibility of an artifact. Firstly,
the large number of nonnative NOEs observed between the
ﬁrst a-helix and the patch formed by residues Thr42 to Leu46.
Secondly, residues Leu45 to Leu46 were unambiguously
assigned and their methyl protons are the most upﬁeld-
shifted protons of the spectra, showing facile distinguishable
contacts with other regions of the protein (Supplementary
Material, Table S1). And ﬁnally, the rotation of the last two
helices is observed during molecular dynamics simulations
(by using the standard AMBER force ﬁeld) of the in silico
constructed CACW40A (L. A. Alcaraz, unpublished results).
Taken together, these results support the view that nonnative
hydrophobic interactions and nonnative structural rearrange-
ments occur in partially unfolded states and, probably, in
folding intermediates.
The structural differences observed for the monomeric
form of CAC, as revealed by the NMR results with mutant
CACW40A, are entirely consistent with the previous
thermodynamic data obtained for the monomeric and dimeric
forms of CAC and other CAC mutants (21–23). Speciﬁcally,
the observation is that a-helix 2 is not stably formed and that
the packing of some residues is altered—which is consistent
with the reduced stability of both CACW40A and the
monomeric intermediate, relative to each subunit in the fully
formed dimeric CAC (21). Finally, the structure is also
consistent with our predictions that the monomeric species of
CAC: 1), lacks some of the native tertiary interactions seen in
the dimer; and 2), has a conformation that differs from that of
the subunits in the dimer (21,22).
Flexibility in CAC and possible
biological implications
Our study of the solution structure of CACW40A indicates
that CAC, while preserving most of the native scaffold, is
structurally highly ﬂexible. In this regard, our results resem-
ble those obtained with a bovine pancreatic trypsin inhibitor
mutant whose structure is nativelike, but whose dynamics is
highly altered relative to the nonmutated protein (72). How-
ever, one question can be raised: is the ﬂexibility observed in
CACW40A a consequence of the mutation (as it is in bovine
pancreatic trypsin inhibitor), or, alternatively, is it intrinsic to
the CAC domain and is it only enhanced by the mutation,
which yields a monomeric species? We will try to answer this
question by comparing the different structural changes de-
tected in CAC in three previous studies and in the present one.
In the ﬁrst study it was proposed, based on the NMR
structure of a structurally homologous CAC protein, that the
MHR of CAC forms dimeric swapped domains (73) during
assembly of the immature particle, within the context of the
intact Gag protein. The authors propose that the MHR of
CAC in one of the monomers moves out and disrupts the
intramonomer contacts between the 310-helix and the hydro-
phobic residues in the ﬁrst a-helix. Concomitantly, a-helix
2, which forms most of the dimerization region of CAC, is
pushed toward the 310-helix of the other monomer. Thus, the
nativelike scaffold remains mainly nativelike, but nonnative
interactions involve the other monomer and the second
dimerization helix of CAC. Furthermore, an aromatic res-
idue, homologous to Phe17 in CACW40A, shows contacts
with other regions of the domain. We have shown here that
in CACW40A, the 310-helix is ﬂexible and that Phe
17 adopts
nonnative contacts, indicating a plasticity for the N-terminal
region. While this article was being reviewed, the x-ray
structure of a dimeric domain swapped variant of the CAC
has been reported by the same authors (74). This domain-
swapped structure is obtained by a single deletion mutant in
CAC (the Ala33), where the swapping zones are the N-terminal
region and the ﬁrst a-helix; on the other hand, the MHR-
containing region is involved in the dimerization interface
(74); furthermore, the a-helix 2 region appeared slightly
shorter than in the dimeric protein.
In a second study, the four-helix bundle scaffold of each
subunit in dimeric CAC is altered by the binding of a
heterologous peptide to form a ﬁve-helix bundle, as shown
by x ray (67). Most of the structure of the protein remains
unaltered except for the second helix (the dimerization
helix), which is displaced 6 A˚ toward the ﬁrst helix. More-
over, the majority of the new contacts with the binding
peptide occur through the patch of hydrophobic residues
Val21, Phe24, Tyr25, Leu28, Arg29, Glu43, Leu46, Leu68, and
Met71. The shift changes the dimerization interface of CAC,
although the protein is still a dimer. Thus, this study shows
that the middle and the C-cap of the ﬁrst helix, and the C-cap
of the second helix, have a tendency to adopt nonnative
contacts. Interestingly enough, the residues involved are
nearly the same observed to adopt nonnative contacts in
CACW40A. Then, preventing dimerization, due to the tryp-
tophan to alanine replacement, leads to a tertiary structure of
CAC that looks similar in some regions (but not in others) to
that observed in the peptide-bound dimer (67), although the
signiﬁcance of this observation remains to be established.
In a third study it was proposed, based on FTIR, ﬂuo-
rescence, and theoretical analyses, that upon binding to lipid
membranes, CAC remains dimeric, but the region around
Trp40 and, thus the dimerization helix, shows large structural
changes (75). Furthermore, the third and fourth helices also
seem conformationally altered, while the rest of the structure
is nativelike.
In brief, those three studies reveal that, upon binding to
other molecules (lipids, peptides, or other regions of the Gag
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protein), the molecular environment around the dimerization
helix might be substantially altered. In the monomeric
CACW40A mutant, the absence of intermonomer (quater-
nary) interactions favors the unfolding of the second helix and
makes the orientation of the last two helices change. In fact,
different biophysical techniques (Table 1 and (21,23)), and
molecular dynamics simulations (L. A. Alcaraz, unpublished
results) suggest that this region ﬂuctuates between the native-
like conformation and other more disordered states. It seems
that the plasticity shown by the CAC domain (when faced to
different molecular environments) relies on the second helical
region, and the changes in this region trigger the changes in
the aromatic residues, in the 310-helix, in the second helix, or
in the second, third, and fourth helices (67,73–75). Further, in
CACW40A, the orientation of the last two helices is also
altered to hide from the solvent the hydrophobic residues of
the second helix. Taken together, these ﬁndings suggest that
the multiple roles of CA during assembly of HIV may be
mediated by its rather unique ability to adopt different confor-
mations while preserving a similar scaffold in response to
different molecular environments.
The fact that the dimerization helix of CAC is not
conformationally stable without the intermonomer (quater-
nary) contacts may also have important implications for the
design of drugs able to effectively inhibit the assembly of the
HIV-1 capsid by disrupting the CA dimerization interface.
We have previously shown that a short peptide comprising
the second helical region of CAC (residues Ser34 to Val57) is
unfolded in solution, but it is able to bind CAC with an
afﬁnity that approached that of the complete CAC domain
(76). Similar studies with other peptides have shown that
upon binding the peptide acquires a helical conformation,
but the exact structure when the peptide is isolated in
solution is unknown (67,77). The entropic cost of binding an
unstructured peptide that mimics the CAC dimerization
interface could not detract from its inhibitory capacity, as a
similar entropic cost would have to be paid during the
formation of helix 2 on dimerization of CA during assembly
of the HIV-1 capsid.
Coordinate and data deposition
The 1H and 15N assignments have been deposited in the
BioMagRes bank, BMRB accession No. 15137. The atomic
coordinates for an ensemble of 30 structures that represent
the solution structure of CACW40A have been deposited in
the Protein Data Bank together with the list of restraints used
for the structure calculation, PDB code No. 2jo0.
SUPPLEMENTARY MATERIAL
To view all of the supplemental ﬁles associated with this
article, visit www.biophysj.org. The assignment list of
CACW40A is shown in Table S1.
We thank the two anonymous reviewers for critical ideas and thoughtful
suggestions. We thank Drs. M. Bruix and M. A. Jime´nez for critical reading
of the article. We deeply thank May Garcı´a, Marı´a del Carmen Fuster,
Javier Casanova, Marı´a T. Garzo´n, Helena Lo´pez, and Eva Martı´nez for
excellent technical assistance.
This work was supported by grants from Ministerio de Sanidad y Consumo
(MSC) (grant No. FIS 01/0004-02) and Ministerio de Educacio´n y Ciencia
(MEC) (grant No. CTQ2005-00360/BQU) to J.L.N., grants from MSC (No.
FIS 01/0004-01) and MEC (No. BIO2003-04445) to M.G.M., and by
institutional grants from Grupo Urbasa to the Instituto de Biologı´a
Molecular and Celular and from Fundacio´n Ramo´n Areces to the Centro
de Biologı´a Molecular ‘‘Severo Ochoa’’. F.N.B. was the recipient of a
predoctoral fellowship from MEC. M.A. was the recipient of a research
fellowship from Comunidad Auto´noma de Madrid.
REFERENCES
1. Freed, E. O. 1998. HIV-1 Gag proteins: diverse functions in the virus
life cycle. Virology. 251:1–15.
2. Freed, E. O., and M. Martin. 2001. HIVs and their replication. In
Field Virology. D. M. Knipe and P. M. Howley, editors. Lippincott,
Philadelphia, PA.
3. Vogt, V. M. 1996. Proteolytic processing and particle maturation.
Curr. Top. Microbiol. Immunol. 214:95–132.
4. Fuller, T. W., T. Wilk, B. E. Gowen, H.-G. Kra¨usslich, and V. M.
Vogt. 1997. Cryo-electron microscopy reveals ordered domains in the
immature HIV-1 particle. Curr. Biol. 7:729–738.
5. Ehrlich, L. S., B. E. Agresta, and C. A. Carter. 1992. Assembly of recom-
binant human immunodeﬁciency virus type 1 capsid protein in vitro.
J. Virol. 66:4874–4883.
6. Gross, I., H. Hohenberg, and H.-G. Kra¨usslich. 1997. In vitro assembly
properties of puriﬁed bacterially expressed capsid proteins of human
immunodeﬁciency virus. Eur. J. Biochem. 249:592–600.
7. Gross, I., H. Hohenberg, C. Huckangel, and H.-G. Kra¨usslich. 1998.
N-terminal extension of human immunodeﬁciency virus capsid protein
converts the in vitro assembly phenotype from tubular to spherical
particles. J. Virol. 72:4798–4810.
8. Ganser, B. K., S. Li, V. Y. Kliskho, J. T. Finch, and W. I. Sundquist.
1999. Assembly and analysis of conical models for the HIV-1 core.
Science. 283:80–83.
9. Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch. 2000. Image
reconstructions of helical assemblies of the HIV-1 CA protein. Nature.
407:409–413.
10. Ehrlich, L. S., T. Liu, S. Scarlata, B. Chu, and C. A. Carter. 2001. HIV-1
capsid proteins forms spherical (immature-like) and tubular (mature-
like) particles in vitro: structure switching by pH-induced conforma-
tional changes. Biophys. J. 81:586–594.
11. von Schwedler, U. K., T. L. Stemmler, V. Y. Kliskho, S. Li, K. H.
Albertine, D. R. Davis, and W. I. Sundquist. 1998. Proteolytic
refolding of the HIV-1 capsid protein amino-terminus facilitates viral
core assembly. EMBO J. 17:1555–1568.
12. Forshey, B. M., U. K. von Schwedler, W. I. Sundquist, and C. Aiken.
2002. Formation of a human immunodeﬁciency virus type 1 core of
optimal stability is crucial for viral replication. J. Virol. 76:5667–
5677.
13. Tang, S., T.Murakami, B. E. Agresta, S. Campbell, E. O. Freed, and J. G.
Levin. 2001. Human immunodeﬁciency virus type 1 N-terminal capsid
mutants that exhibit aberrant coremorphology are blocked in initiation of
reverse transcription in infected cells. J. Virol. 75:9357–9366.
14. Borsetti, A., A˚. O¨hagen, and H. G. Go¨ttlinger. 1998. The C-terminal
half of the human immunodeﬁciency virus type 1 Gag precursor is
sufﬁcient for efﬁcient particle assembly. J. Virol. 72:9313–9317.
15. Wang, C. T., and E. Barklis. 1993. Assembly, processing and infec-
tivity of human immunodeﬁciency virus type 1 Gag mutants. J. Virol.
67:4264–4273.
1274 Alcaraz et al.
Biophysical Journal 93(4) 1264–1276
16. Momany, C., L. C. Kovari, A. J. Prongay, W. Keller, R. K. Gitti, B. M.
Lee, A. E. Gorbalenya, L. Tong, J. McClure, L. S. Ehrlich, M. F.
Summers, C. Carter, and M. G. Rossmann. 1996. Crystal structure of
dimeric HIV-1 capsid protein. Nat. Struct. Biol. 3:763–770.
17. Gitti, R. K., B. M. Lee, J. Walker, M. F. Summers, S. Yoo, and W. I.
Sundquist. 1996. Structure of the amino-terminal core domain of the
HIV-1 capsid protein. Science. 273:231–235.
18. Gamble, T. R., F. F. Vajdos, S. Yoo, D. K. Worthylake, M.
Houseweart, W. I. Sundquist, and C. P. Hill. 1996. Crystal structure
of human cyclophilin A bound to the amino-terminal domain of HIV-
1 capsid. Cell. 87:1285–1294.
19. Gamble, T. R., S. Yoo, F. F. Vajdos, U. K. von Schwedler, D. K.
Worthylake, H. Wang, J. P. McCutcheon, W. I. Sundquist, and C. P.
Hill. 1997. Structure of the carboxyl-terminal dimerization domain of
the HIV-1 capsid protein. Science. 278:849–853.
20. Worthylake, D. K., H. Wang, S. Yoo, W. I. Sundquist, and C. P. Hill.
1999. Structures of the HIV-1 capsid protein dimerization domain at
2.6 A˚ resolution. Acta Crystallogr. D55:85–92.
21. Mateu, M. G. 2002. Conformational stability of dimeric and mono-
meric forms of the C-terminal domain of human immunodeﬁciency
virus-1 capsid protein. J. Mol. Biol. 318:519–531.
22. Lido´n-Moya, M. C., F. N. Barrera, M. Bueno, R. Pe´rez-Jime´nez, J.
Sancho, M. G. Mateu, and J. L. Neira. 2005. An extensive thermo-
dynamic characterization of the dimerization domain of the HIV-
1 capsid protein. Protein Sci. 14:2387–2404.
23. del Alamo, M., J. L. Neira, and M. G. Mateu. 2003. Thermodynamic
dissection of a low-afﬁnity protein-protein interface involved in human
immunodeﬁciency virus assembly. J. Biol. Chem. 278:27923–27929.
24. Pace, C. N., and J. M. Scholtz. 1997. Measuring the conformational
stability of a protein. In Protein Structure, 2nd Ed. T. E. Creighton,
editor. Oxford University Press, Oxford.
25. Echabe, I., J. A. Encinar, and J. L. R. Arrondo. 1997. Removal of
spectral noise in the quantitation of protein structure through infrared
band decomposition. Biospectroscopy. 3:469–475.
26. Wishart, D. S., C. G. Bigam, J. Yao, F. Abilgaard, H. J. Dyson, E.
Oldﬁeld, J. L. Markley, and B. D. Sykes. 1995. 1H,13C and 15N
chemical shift referencing in biomolecular NMR. J. Biomol. NMR.
6:135–141.
27. Price, W. S. 1997. Pulse-ﬁeld gradient nuclear magnetic resonance as a
tool for studying translational diffusion. I. Basic theory. Concepts
Magn. Reson. 9:299–336.
28. Price, W. S. 1998. Pulse-ﬁeld gradient nuclear magnetic resonance as a
tool for studying translational diffusion. II. Experimental aspects.
Concepts Magn. Reson. 10:197–237.
29. Lapham, J., J. P. Rife, P. B. Moore, and D. M. Crothers. 1997. Measure-
ment of diffusion constants for nucleic acids by NMR. J. Biomol. NMR.
10:255–262.
30. Marion, D., and K. Wu¨thrich. 1983. Application of phase sensitive
two-dimensional correlated spectroscopy (COSY) for measurements of
1H-1H spin-spin coupling constants in proteins. Biochem. Biophys. Res.
Commun. 11:967–975.
31. States, D. J., R. A. Haberkorn, and D. J. Ruben. 1982. A two-dimen-
sional nuclear Overhauser experiment with pure absorption phase in
four quadrants. J. Magn. Reson. 48:286–292.
32. Braunschweiler, L., and R. R. Ernst. 1983. Coherence transfer by
isotropic mixing: application to proton correlation spectroscopy. J.
Magn. Reson. 53:521–528.
33. Bax, A., and D. G. Davis. 1985. MLEV-17 based two-dimensional
homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:
355–360.
34. Jeener, J., B. H. Meier, P. Bachmann, and R. R. Ernst. 1979. Investiga-
tion of exchange processes by two-dimensional NMR spectroscopy.
J. Chem. Phys. 71:4546–4553.
35. Piotto, M., V. Saudek, and V. Sklenar. 1993. Gradient-tailored
excitation for single-quantum NMR spectroscopy of aqueous solutions.
J. Biomol. NMR. 2:661–665.
36. Bodenhausen, G., and D. J. Ruben. 1980. Natural abundance nitrogen-
15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett.
69:185–188.
37. Zhang, O., L. E. Kay, J. P. Olivier, and J. D. Forman-Kay. 1994.
Backbone 1H and 15N resonance assignments of the N-terminal SH3
domain of DRK in folded and unfolded states using enhanced-sensitivity
pulsed ﬁeld gradient NMR techniques. J. Biomol. NMR. 4:845–858.
38. Vuister, G. W., and A. D. Bax. 1993. Quantitative J correlation: a new
approach for measuring homonuclear three-bond J(HNHa) coupling
constants in 15N enriched proteins. J. Am. Chem. Soc. 115:7772–7777.
39. Wu¨thrich, K. 1986. NMR of Proteins and Nucleic Acids. J. Wiley and
Sons, New York.
40. Goddard, T. D., and D. G. Kneller. 2004. SPARKY. University of
California, San Francisco, CA.
41. Gu¨ntert, P., C. Mumenthaler, and K. Wu¨thrich. 1997. Torsion angle
dynamics for NMR structure calculation with the new program
DYANA. J. Mol. Biol. 273:283–298.
42. Gu¨ntert, P., W. Braun, and K. Wu¨thrich. 1991. Efﬁcient computation of
three-dimensional protein structures in solution from nuclear magnetic
resonance data using the program DIANA and the supporting programs
CALIBA, HABAS and GLOMSA. J. Mol. Biol. 217:517–530.
43. Cavanagh, J. F., J. Wayne, A. G. Palmer III, and N. J. Skelton. 1996.
Protein NMR Spectroscopy: Principles and Practice. Academic Press,
San Diego, CA.
44. Case, D. A., D. A. Pearlman, J. W. Cadwell, W. S. Ross, T. E.
Cheatman, D. M. Ferguson, G. L. Seible, U. C. Singh, P. K. Weiner,
and P. A. Kollman. 2003. AMBER 8. University of California, San
Francisco, CA.
45. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thorton.
1993. PROCHECK: a program to check the stereochemical quality of
protein structures. J. Appl. Crystallogr. 26:283–291.
46. Laskowski, R. A., J. A. C. Rullmann, M. W. MacArthur, R. Kaptein,
and J. M. Thronton. 1996. AQUA and PROCHECK-NMR: pro-
grams for checking the quality of proteins structures solved by NMR.
J. Biomol. NMR. 8:477–486.
47. DeLano, W. L. 2002. The PyMOL Molecular Graphics System.
DeLano Scientiﬁc, San Carlos, CA.
48. Koradi, R., M. Billeter, and K. Wu¨thrich. 1996. MOLMOL: a program for
display and analysis ofmacromolecular structure.J.Mol.Graph. 14:51–55.
49. Surewicz, W. K., and H. H. Mantsch. 1988. New insight into protein
secondary structure from resolution-enhanced infrared spectra. Bio-
chim. Biophys. Acta. 952:115–130.
50. Arrondo, J. L., and F. M. Goni. 1999. Structure and dynamics of
membrane proteins as studied by infrared spectroscopy. Prog. Biophys.
Mol. Biol. 72:367–405.
51. Surewicz, W. K., H. H. Mantsch, and D. Chapman. 1993. Determi-
nation of protein secondary structure by FT-IR. A critical assessment.
Biochemistry. 32:389–394.
52. Chehin, R., I. Iloro, M. J. Marcos, E. Villar, V. L. Shnyrov, and J. L.
Arrondo. 1999. Thermal and pH-induced conformational changes of a
beta-sheet protein monitored by infrared spectroscopy. Biochemistry.
38:1525–1530.
53. Shaw, R. A., G. W. Buchko, G. Wang, A. Rozek, W. D. Treleaven,
H. H. Mantsch, and R. J. Cushley. 1997. Infrared spectroscopy of human
apolipoprotein fragments in SDS/D2O: relative lipid-binding afﬁnities
and a novel amide I assignment. Biochemistry. 36:14531–14538.
54. Cantor, C. R., and P. R. Schimmel. 1980. Biophysical Chemistry.
W. H. Freeman and Company, New York.
55. Creighton, T. E. 1993. Proteins. Structures and Macromolecular
Properties, 2nd Ed. W. H. Freeman, New York.
56. Price, W. S., F. Tsuchiya, and Y. Arata. 2001. Time dependence of
aggregation in crystallizing lysozyme solutions probed by using NMR
self-diffusion measurements. Biophys. J. 80:1585–1590.
57. Narayanan, S., B. Bo¨sl, S. Walter, and B. Reif. 2003. Importance of
low-oligomeric-weight species for prion propagation in the yeast prion
system Sup35/Hsp104. Proc. Natl. Acad. Sci. USA. 100:9286–9291.
Solution Structure of Monomeric CAC 1275
Biophysical Journal 93(4) 1264–1276
58. Moreau, V. H., A. C. da Silva, R. M. P. Siloto, A. P. Valente, A. Leite,
and F. C. L. Almeida. 2004. The bZIP region of the plant transcription
factor opaque-2 forms stable homodimers in solution and retains its
helical structure upon subunit dissociation. Biochemistry. 43:4862–4868.
59. Price, W. S., M. Nara, and Y. Arata. 1997. A pulse ﬁeld gradient NMR
study of the aggregation and hydration of parvalbumin. Biophys. Chem.
65:179–187.
60. Dingley, A. J., J. P. Mackay, B. E. Caphaman, M. B. Morris, P. W.
Kuchel, B. D. Hambly, and G. F. King. 1995. Measuring protein self-
association using pulsed-ﬁeld-gradient NMR spectroscopy: application
to myosin light chain 2. J. Biomol. NMR. 6:321–328.
61. Altieri, A. S., D. P. Hinton, and R. A. Byrd. 1995. Association of
biomolecular systems via pulsed ﬁeld gradient NMR self-diffusion
measurements. J. Am. Chem. Soc. 117:7566–7567.
62. Ilyina, E., V. Roongta, H. Pan, C. Woodward, and K. H. Mayo. 1997.
A pulse ﬁeld gradient NMR study of bovine pancreatic trypsin inhibitor
self-association. Biochemistry. 36:3383–3388.
63. Choy, W. Y., F. A. Mulder, K. A. Crowhurst, D. R. Muhandiram, I. S.
Millett, S. Doniach, J. D. Forman-Kay, and L. E. Kay. 2002.
Distribution of molecular size within an unfolded state ensemble using
small-angle x-ray scattering and pulse ﬁeld gradient NMR techniques.
J. Mol. Biol. 316:101–112.
64. Casares, S.,M. Sadqi, O. Lo´pez-Mayorga, F. Conejero-Lara, andN.A. J.
van Nuland. 2004. Detection and characterization of partially unfolded
oligomers of the SH3 domain of a-spectrin. Biophys. J. 86:2403–2413.
65. Fischer, M. W. F., A. Majumdar, and E. R. P. Zuiderweg. 1998.
Protein NMR relaxation: theory, applications and outlook. Progress
NMR Spectrosc. 33:207–272.
66. Eliezer, D., and P. E. Wright. 1996. Is apomyoglobin a molten globule?
Structural characterization by NMR. J. Mol. Biol. 263:531–538.
67. Ternois, F., J. Stitch, S. Duquerroy, H.-G. Kra¨usslich, and F. A. Rey.
2005. The HIV-1 capsid protein C-terminal domain in complex with a
virus assembly inhibitor. Nat. Struct. Mol. Biol. 12:678–682.
68. Kelly, S. M., and N. C. Price. 2000. The use of circular dichroism in
the investigation of protein structure and function. Curr. Protein
Peptide Sci. 1:349–384.
69. Woody, R. W. 1995. Circular dichroism. Methods Enzymol. 246:
34–71.
70. Mayor, U., N. R. Guydosh, C. M. Johnson, G. Grossmann, S. Sato,
G. S. Jas, S. M. V. Freund, D. O. V. Alonso, V. Daggett, and A. R. Fersht.
2003. The complete folding pathway of a protein from nanosecond to
microsecond. Nature. 42:863–867.
71. Feng, H., H. Takei, R. Lipsitz, N. Tjandra, and Y. Bai. 2003. Speciﬁc
non-native interactions in a hidden folding intermediate: implications
for protein folding. Biochemistry. 42:12461–12465.
72. Battiste, J. L., R. Li, and C. Woodward. 2002. A highly destabilizing
mutation of G37A of the bovine pancreatic trypsin inhibitor retains the
average native conformation but greatly increases local ﬂexibility.
Biochemistry. 41:2237–2245.
73. Ivanov, D., J. R. Stone, J. L. Maki, T. Collins, and G. Wagner. 2005.
Mammalian SCAN domain dimer is a domain swapped homolog of the
HIV capsid C-terminal domain. Mol. Cell. 17:137–143.
74. Ivanov, D., O. V. Tsodikov, J. Kasanov, T. Elenberger, G. Wagner,
and T. Collins. 2007. Domain-swapped dimerization of the HIV-1
capsid C terminal domain. Proc. Natl. Acad. Sci. USA. 104:4353–4358.
75. Barrera, F. N., E. Hurtado-Go´mez, M. C. Lido´n-Moya, and J. L. Neira.
2006. Binding of the C-terminal domain of the HIV-1 capsid protein
to lipid membranes: a biophysical characterization. Biochem. J. 394:
345–353.
76. Garzo´n, M. T., M. C. Lido´n-Moya, F. N. Barrera, A. Prieto, J. Go´mez,
M. G. Mateu, and J. L. Neira. 2004. The dimerization domain of the
HIV-1 capsid protein binds a capsid protein-derived peptide: a bio-
physical characterization. Protein Sci. 13:1512–1523.
77. Stitch, J., M. Humbert, S. Fidnlow, J. Bodem, B. Mu¨ller, U. Dietrich, J.
Werner, and H.-G. Kra¨usslich. 2005. A peptide inhibitor of the HIV-
1 assembly in vitro. Nat. Struct. Mol. Biol. 12:671–677.
1276 Alcaraz et al.
Biophysical Journal 93(4) 1264–1276
